Sugi Predict

Sugi Predict / Compounds / SCHEMBL8655477

SCHEMBL8655477

SCHEMBL8655477

CC(C)N(C(C)C)P(O)OCCC#N.Cc1cn([C@H]2C[C@H](O)[C@@H](CNC(c3ccccc3)(c3ccccc3)c3ccccc3)O2)c(=O)[nH]c1=O

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DUT P33316 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8654707 0.88 TYMP (0.46) —
SCHEMBL8658996 0.88 TK1 (0.44) —
SCHEMBL8655483 0.86 RNASE1 (0.42) DUT
Doxribtimine SCHEMBL8742401 0.86 TK1 (0.51) —
SCHEMBL8658998 0.84 RNASE1 (0.41) —
SCHEMBL8655891 0.83 DUT (0.71) DUT
SCHEMBL8655889 0.83 DUT (0.71) DUT
SCHEMBL2710677 0.82 RNASE1 (0.39) DUT
SCHEMBL19775782 0.80 TK2 (0.41) —
SCHEMBL17279162 0.80 TK2 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807837-A ADMINISTERING TO TREAT HIV INFECTIONS TO INHIBIT THE REPLICATION OF FOREIGN NUCLEIC ACIDS IN A NORMAL CELL SANKYO COMPANY, LIMITED (JP) 1998-09-15 — — US disclosed
US-5674856-A TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS, INCLUDING AIDS AND TUMORS SANKYO COMPANY, LIMITED (JP) 1997-10-07 — — US disclosed
EP-0611075-B1 Modified oligodeoxyribonucleotides, their preparation and their therapeutic use SANKYO CO (JP) 1996-12-18 — — EP disclosed
EP-0611075-A1 Modified oligodeoxyribonucleotides, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-08-17 — — EP disclosed